JP2017501237A5 - - Google Patents

Download PDF

Info

Publication number
JP2017501237A5
JP2017501237A5 JP2016562466A JP2016562466A JP2017501237A5 JP 2017501237 A5 JP2017501237 A5 JP 2017501237A5 JP 2016562466 A JP2016562466 A JP 2016562466A JP 2016562466 A JP2016562466 A JP 2016562466A JP 2017501237 A5 JP2017501237 A5 JP 2017501237A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
cycloalkyl
membered
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016562466A
Other languages
English (en)
Japanese (ja)
Other versions
JP6476205B2 (ja
JP2017501237A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/010090 external-priority patent/WO2015103510A1/en
Publication of JP2017501237A publication Critical patent/JP2017501237A/ja
Publication of JP2017501237A5 publication Critical patent/JP2017501237A5/ja
Application granted granted Critical
Publication of JP6476205B2 publication Critical patent/JP6476205B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016562466A 2014-01-06 2015-01-05 RORγ修飾因子としてのヘテロ環式スルホン Expired - Fee Related JP6476205B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461923904P 2014-01-06 2014-01-06
US61/923,904 2014-01-06
PCT/US2015/010090 WO2015103510A1 (en) 2014-01-06 2015-01-05 Heterocyclic sulfone as ror-gamma modulators

Publications (3)

Publication Number Publication Date
JP2017501237A JP2017501237A (ja) 2017-01-12
JP2017501237A5 true JP2017501237A5 (enExample) 2018-01-25
JP6476205B2 JP6476205B2 (ja) 2019-02-27

Family

ID=52392247

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016562466A Expired - Fee Related JP6476205B2 (ja) 2014-01-06 2015-01-05 RORγ修飾因子としてのヘテロ環式スルホン

Country Status (6)

Country Link
US (1) US9637455B2 (enExample)
EP (1) EP3092221B1 (enExample)
JP (1) JP6476205B2 (enExample)
CN (1) CN106061956B (enExample)
ES (1) ES2705400T3 (enExample)
WO (1) WO2015103510A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3044219A1 (en) 2013-09-09 2016-07-20 Bristol-Myers Squibb Company Rorgamma modulators
EP3046906B1 (en) 2013-09-20 2017-08-16 Bristol-Myers Squibb Company Ror gamma modulators
EP3092216B1 (en) 2014-01-06 2018-12-12 Bristol-Myers Squibb Company Carbocyclic sulfone ror gamma modulators
CN106061956B (zh) 2014-01-06 2021-03-12 百时美施贵宝公司 作为RORγ调节剂的杂环砜
US9708253B2 (en) 2014-01-06 2017-07-18 Bristol-Myers Squibb Company Cyclohexyl sulfone RORγ modulators
CA2936116A1 (en) 2014-01-06 2015-07-09 Bristol-Myers Squibb Company Pyrrolidinyl sulfone derivatives and their use as ror gamma modulators
SMT201900706T1 (it) 2014-10-30 2020-01-14 Janssen Pharmaceutica Nv Tiazoli sostituiti con ammide come modulatori di rorgammat
JOP20200117A1 (ar) 2014-10-30 2017-06-16 Janssen Pharmaceutica Nv كحولات ثلاثي فلوروميثيل كمُعدلات للمستقبل النووي جاما تي المرتبط بحمض الريتيونَويك ROR?t
RS58250B1 (sr) 2014-10-30 2019-03-29 Janssen Pharmaceutica Nv Tiazoli kao modulatori roryt
ES2887087T3 (es) 2015-05-07 2021-12-21 Bristol Myers Squibb Co Sulfonas tricíclicas como moduladores ROR gamma
TW201803869A (zh) 2016-04-27 2018-02-01 健生藥品公司 作為RORγT調節劑之6-胺基吡啶-3-基噻唑
KR102599437B1 (ko) * 2016-11-09 2023-11-07 브리스톨-마이어스 스큅 컴퍼니 Ror 감마 조정제로서의 트리시클릭 술폰
ES2928246T3 (es) 2018-06-18 2022-11-16 Janssen Pharmaceutica Nv 6-aminopiridin-3-il pirazoles como moduladores de RORyt
US10975037B2 (en) 2018-06-18 2021-04-13 Janssen Pharmaceutica Nv Phenyl substituted pyrazoles as modulators of RORγt
JP2021527660A (ja) 2018-06-18 2021-10-14 ヤンセン ファーマシューティカ エヌ.ベー. RORγtのモジュレータとしてのフェニル及びピリジニル置換イミダゾール
CN112292373A (zh) 2018-06-18 2021-01-29 詹森药业有限公司 作为RORγt的调节剂的吡啶基吡唑类

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE735866C (de) * 1941-01-17 1943-06-11 Ig Farbenindustrie Ag Verfahren zur Darstellung von Aminoalkylsulfonverbindungen
US2802013A (en) * 1954-02-12 1957-08-06 Searle & Co 2-(oxo and imino)-3-(phenyl and halophenyl)-tetrahydrofuransulfones and processes for the manufacture thereof
US3016403A (en) * 1955-07-29 1962-01-09 Searle & Co 1-aryl-3-hydroxypropyl sulfones and processes
US2812330A (en) 1956-05-02 1957-11-05 Searle & Co Sulfone derivatives of 2, 6-piperidinedione
GB0108591D0 (en) * 2001-04-05 2001-05-23 Merck Sharp & Dohme Therapeutic agents
AU2002367147A1 (en) 2001-12-27 2003-07-15 Daiichi Pharmaceutical Co., Ltd. Beta-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
US20110251172A1 (en) * 2008-08-13 2011-10-13 Rivkin Alexey A Purine derivatives for treatment of alzheimer's disease
US20130190356A1 (en) * 2011-12-22 2013-07-25 Genentech, Inc. Benzyl sulfonamide derivatives as rorc modulators
US9266827B2 (en) 2012-05-08 2016-02-23 Merck Sharp & Dohme Corp. Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of disease
WO2014028669A1 (en) * 2012-08-15 2014-02-20 Biogen Idec Ma Inc. Novel compounds for modulation of ror-gamma activity
WO2014062938A1 (en) 2012-10-19 2014-04-24 Bristol-Myers Squibb Company Rory modulators
EP3044219A1 (en) 2013-09-09 2016-07-20 Bristol-Myers Squibb Company Rorgamma modulators
EP3046906B1 (en) 2013-09-20 2017-08-16 Bristol-Myers Squibb Company Ror gamma modulators
US9708253B2 (en) 2014-01-06 2017-07-18 Bristol-Myers Squibb Company Cyclohexyl sulfone RORγ modulators
CN106061956B (zh) 2014-01-06 2021-03-12 百时美施贵宝公司 作为RORγ调节剂的杂环砜
CA2936116A1 (en) 2014-01-06 2015-07-09 Bristol-Myers Squibb Company Pyrrolidinyl sulfone derivatives and their use as ror gamma modulators
EP3092216B1 (en) 2014-01-06 2018-12-12 Bristol-Myers Squibb Company Carbocyclic sulfone ror gamma modulators

Similar Documents

Publication Publication Date Title
JP2017501237A5 (enExample)
JP2017508782A5 (enExample)
JP2017509689A5 (enExample)
JP2016506369A5 (enExample)
RU2020110780A (ru) Ингибитор fgfr и его медицинское применение
JP2016514159A5 (enExample)
JP2016503799A5 (enExample)
JP2019501125A5 (enExample)
JP2018515438A5 (enExample)
JP2018522879A5 (enExample)
JP2019535723A5 (enExample)
JP2013537203A5 (enExample)
JP2012041349A5 (enExample)
JP2016532715A5 (enExample)
JP2019524883A5 (enExample)
JP2018516238A5 (enExample)
JP2018519245A5 (enExample)
JP2013502441A5 (enExample)
JP2015537008A5 (enExample)
JP2018516904A5 (enExample)
RU2016134751A (ru) Соединения
JP2015522650A5 (enExample)
RU2017144495A (ru) Противогельминтные депсипептидные соединения
JP2013544860A5 (enExample)
JP2016531126A5 (enExample)